sofidexFor patientsAre you a clinician? Clinical site

Meds & supplements  ›  Betamethasone

Medicine

Betamethasone

Betamethasone dipropionate cream (augmented) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older.

Prescribing label

Selected manufacturer label information, organised into consistent sections by Sofidex. This source is written for healthcare professionals; ask your pharmacist to explain instructions that are unclear. Read the full label at DailyMed ↗

Drug facts

Used for
Betamethasone dipropionate cream (augmented) is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older.
How to take it
Apply a thin film of betamethasone dipropionate cream to the affected skin areas once daily.
Do not take if
Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

What it is used for

Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

How to take it

Apply a thin film of betamethasone dipropionate cream to the affected skin areas once daily. In some cases, twice daily dosage may be necessary.

If an infection develops, appropriate antimicrobial therapy should be instituted.

Betamethasone dipropionate products should not be used with occlusive dressings.

Side effects, and when to stop

The following local adverse reactions are reported infrequently when betamethasone dipropionate products are used as recommended in the DOSAGE AND ADMINISTRATION section. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infections, skin atrophy, striae and miliaria.

Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia and glucosuria in some patients.

Who should not take it

Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

Cite this page

NLM

sofidex [Internet]. Daloreum; c2026. Betamethasone; [reviewed 2026 Aug 2; cited 2026 Nov 10]. Available from: https://sofidex.com/patients/medicines/betamethasone

APA 7th

sofidex. (2026, August 2). Betamethasone. Daloreum. Retrieved November 10, 2026, from https://sofidex.com/patients/medicines/betamethasone

AMA 11th

Betamethasone. sofidex. Reviewed August 2, 2026. Accessed November 10, 2026. https://sofidex.com/patients/medicines/betamethasone

The cited date is today’s, because a citation records when you read the page. The reviewed date is when a clinician last checked it.